Pancreatic Cancer Research

ResearcherInstitut Gustave RoussyNo recent work listed

Antoine Adenis

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3123-9746; OpenAlex author ID A5026512478. Sources: ClinicalTrials.gov.

Their work

Papers
6 (first author 0, last author 1)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2011: 3 papers · 2012: none · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 1 trial · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 6

  1. Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial. Co-author DOI 10.1001/jamaoncol.2022.3829↗
  2. Asparagine Synthetase Expression and Phase I Study With L-Asparaginase Encapsulated in Red Blood Cells in Patients With Pancreatic Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000000394↗
  3. Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomize… Co-author DOI 10.1200/jco.2012.44.4869↗
  4. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. Co-author DOI 10.1056/nejmoa1011923↗
  5. Metastatic pancreatic cancer: old drugs, new paradigms. Last author DOI 10.1097/cco.0b013e3283473610↗
  6. Docetaxel- and 5-FU-concurrent radiotherapy in patients presenting unresectable locally advanced pancreatic cancer: a FNCLCC-ACCORD/0201 randomized phase II tr… Co-author DOI 10.1186/1748-717x-6-124↗

Trials 1

  1. Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy Principal investigator NCT02853474↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Arlette Da Silva · 1 shared trial, 2016 · strength 0.19
  2. Thierry Conroy · 3 shared papers, 2011–2013 · strength 0.10
  3. Marc Ychou · 3 shared papers, 2011–2013 · strength 0.08
  4. Jean‐Baptiste Bachet · 2 shared papers, 2011–2015 · strength 0.06
  5. S. Gourgou-Bourgade · 2 shared papers, 2011–2013 · strength 0.05
  6. Jean‐Luc Raoul · 2 shared papers, 2011–2013 · strength 0.05
  7. Olivier Bouché · 2 shared papers, 2011–2013 · strength 0.05
  8. Michel Pierre Ducreux · 2 shared papers, 2011 · strength 0.04
  9. Raphaël Maréchal · 1 shared paper, 2015 · strength 0.04
  10. Pieter Demetter · 1 shared paper, 2015 · strength 0.04
  11. Magali Svrcek · 1 shared paper, 2015 · strength 0.04
  12. Jerome F. Cros · 1 shared paper, 2015 · strength 0.04
  13. Thierry André · 1 shared paper, 2015 · strength 0.04
  14. Pascal R. Hammel · 1 shared paper, 2015 · strength 0.04
  15. F. Viret · 1 shared paper, 2011 · strength 0.02
  16. Lucie Obéric · 1 shared paper, 2011 · strength 0.02
  17. F. Mornex · 1 shared paper, 2011 · strength 0.02
  18. Bruno Chauffert · 1 shared paper, 2011 · strength 0.02
  19. Pierre Michel · 1 shared paper, 2011 · strength 0.02
  20. Eric Assénat · 1 shared paper, 2011 · strength 0.02
  21. Christelle de la Fouchardière · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.